Enhanced Detection of Adverse Glycemic Events in Hospital with Unmasked Continuous Glucose Monitoring Versus Point-of-Care Testing in People with Type 1 Diabetes.

ABSTRACT:

Background

In people with type 1 diabetes (T1D) admitted to hospital, adverse glycemic events (AGE), both hypoglycemia and hyperglycemia, bestow risk for adverse outcomes. Continuous glucose monitoring (CGM) use is increasingly common amongst people with T1D. We investigated AGE frequency in hospital, based on CGM versus point-of-care (POC) blood glucose measures.

Methods

In this multi-center retrospective analysis of non-critically ill hospitalized adults with T1D who continued wearing their unmasked CGM (FreeStyle Libre 1/2, Dexcom G5/G6, Medtronic Guardian 3) during admission and received standard ward-based POC testing, we compared CGM- and POC-based AGE detection of hypoglycemia (<70 mg/dL) and hyperglycemia (>180 mg/dL).

Results

In 253 admissions, 127 837 CGM an

SUBMITTER: Wang R 

PROVIDER: S-EPMC12672289 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature